scholarly journals A Case of Chronic Ischemic Colitis on the Anal Side of the Anastomosis after Laparoscopic Resection for Splenic Flexure Colon Cancer

Author(s):  
Kyosuke HABU ◽  
Shintaro AKAMOTO ◽  
Yusuke KONISHI ◽  
Tetsuji FUKUHARA ◽  
Kazuhiko NAKAGAWA ◽  
...  
2016 ◽  
Vol 68 (1) ◽  
pp. 71-75 ◽  
Author(s):  
Junji Okuda ◽  
Masashi Yamamoto ◽  
Keitaro Tanaka ◽  
Shinsuke Masubuchi ◽  
Kazuhisa Uchiyama

2019 ◽  
Vol 21 (9) ◽  
pp. 1090-1091 ◽  
Author(s):  
G. Lisi ◽  
G. M. Garbarino ◽  
R. Del Giudice ◽  
D. Spoletini ◽  
M. Carlini

2019 ◽  
Vol 29 (6) ◽  
pp. 483-488
Author(s):  
Michele Grieco ◽  
Diletta Cassini ◽  
Domenico Spoletini ◽  
Enrica Soligo ◽  
Emanuela Grattarola ◽  
...  

Swiss Surgery ◽  
2003 ◽  
Vol 9 (1) ◽  
pp. 3-7 ◽  
Author(s):  
Gervaz ◽  
Bühler ◽  
Scheiwiller ◽  
Morel

The central hypothesis explored in this paper is that colorectal cancer (CRC) is a heterogeneous disease. The initial clue to this heterogeneity was provided by genetic findings; however, embryological and physiological data had previously been gathered, showing that proximal (in relation to the splenic flexure) and distal parts of the colon represent distinct entities. Molecular biologists have identified two distinct pathways, microsatellite instability (MSI) and chromosomal instability (CIN), which are involved in CRC progression. In summary, there may be not one, but two colons and two types of colorectal carcinogenesis, with distinct clinical outcome. The implications for the clinicians are two-folds; 1) tumors originating from the proximal colon have a better prognosis due to a high percentage of MSI-positive lesions; and 2) location of the neoplasm in reference to the splenic flexure should be documented before group stratification in future trials of adjuvant chemotherapy in patients with stage II and III colon cancer.


2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Takatsugu Fujii ◽  
Shigeo Toda ◽  
Yuki Nishihara ◽  
Yusuke Maeda ◽  
Kosuke Hiramatsu ◽  
...  

Medicine ◽  
2016 ◽  
Vol 95 (26) ◽  
pp. e3982 ◽  
Author(s):  
Chang Woo Kim ◽  
Yun Dae Han ◽  
Ha Yan Kim ◽  
Hyuk Hur ◽  
Byung Soh Min ◽  
...  

2019 ◽  
Vol 13 (1) ◽  
pp. 78-84 ◽  
Author(s):  
Ryota Koyama ◽  
Yoshiaki Maeda ◽  
Nozomi Minagawa ◽  
Toshiki Shinohara ◽  
Tomonori Hamada

We report the case of a 65-year-old male with a metachronous abdominal wall metastasis secondary to colorectal cancer. The patient had presented 5 years ago to another facility with a perforated sigmoid colon cancer (pT4a[SE], N0, M0, pStage II), rectal cancer (T2[MP], N0, M0, pStage I), and Fournier gangrene. He had then undergone sigmoidectomy and rectal resection along with S-1 adjuvant chemotherapy. No relapse was observed thereafter. However, currently, 5 years after initial surgery, the patient noticed a palpable mass in the left lower abdomen and was referred to our hospital for further assessment and treatment. Percutaneous echo-guided needle biopsy of the tumor revealed an adenocarcinoma tissue. Following 6 courses of FOLFOX plus cetuximab chemotherapy, laparoscopic resection for abdominal wall metastasis was successfully performed. The resected tissue was pathologically characterized as adenocarcinoma, which was compatible with the recurrence of the primary colorectal carcinoma resected 5 years ago. The abdominal wall metastasis was attributed to the cancer cell implantation secondary to the perforated sigmoid colon cancer treated 5 years ago.


Sign in / Sign up

Export Citation Format

Share Document